We also show that both shRNA-mediated knockdown of PKM2 and pharmacological induction of PKM2 tetramerization (i.e., activation of the pyruvate kinase activity) suppressed the proliferation of cervical cancer cells. Here, PKM is linked to cervical carcinoma.